Daiichi Sankyo has established Daiichi Sankyo Research Institute in San Diego, representing the third research institute established outside of the company’s flagship research centre in Japan since the opening of locations in Boston and Munich in 2024.

Yuki Abe, PhD, Head—R&D Division, Japan and Head—Research, Daiichi Sankyo, said, “Establishing a dedicated scientific presence in San Diego marks a significant milestone for Daiichi Sankyo as we continue to deepen our long-standing relationships in one of the world’s leading innovation hubs and expand our global research strategy. We look forward to further strengthening our research collaborations by embedding our scientists in local life-science ecosystems around the world to help us continue to identify unique and cutting-edge science that can serve as building blocks for the discovery of new medicines.”

Daiichi Sankyo Research Institutes, located in Boston, Munich and San Diego, are advancing the vision of Daiichi Sankyo to foster the development of next-generation medicines by leveraging the expertise of Daiichi Sankyo scientists and building robust research innovation networks that incubate breakthrough science through advanced technology platforms and innovative disease targets.